Danish Pharmacovigilance Update, April 2017
22 May 2017
In this issue
- Ciprofloxacin and risk of polyneuropathy and tendon disease/disorder
- Rosuvastatin and risk of renal effects and rhabdomyolysis
- The DKMA’s annual pharmacovigilance report 2016
- Report on the use of and ADR reports on selected biological medicinal products now available
- EU's list of recommendations on safety signals
- Most recent Direct Healthcare Professional Communications (DHPCs)